These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells. Dorflinger LJ; Schonbrunn A Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245 [TBL] [Abstract][Full Text] [Related]
4. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells. Presky DH; Schonbrunn A Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115 [TBL] [Abstract][Full Text] [Related]
5. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells. Litvin Y; Leiser M; Fleischer N; Erlichman J Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087 [TBL] [Abstract][Full Text] [Related]
7. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function. Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536 [TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium. Koch BD; Dorflinger LJ; Schonbrunn A J Biol Chem; 1985 Oct; 260(24):13138-45. PubMed ID: 2865257 [TBL] [Abstract][Full Text] [Related]
9. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes. Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium. Narayanan N; Lussier B; French M; Moor B; Kraicer J Endocrinology; 1989 Jan; 124(1):484-95. PubMed ID: 2562826 [TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. Perrin MH; Haas Y; Rivier JE; Vale WW Endocrinology; 1986 Mar; 118(3):1171-9. PubMed ID: 3004898 [TBL] [Abstract][Full Text] [Related]
12. Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells. Presky DH; Schonbrunn A J Cell Biol; 1986 Mar; 102(3):878-88. PubMed ID: 2869047 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a biotinylated somatostatin analog as a receptor probe. Schonbrunn A; Lee AB; Brown PJ Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437 [TBL] [Abstract][Full Text] [Related]